Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyInterventionalPublished in a peer-reviewed journal

Human Study on Self-management and Quality of Life in People with MS

In a study involving 55 people with MS, participants reported improvements in self-management, self-efficacy, and quality of life. The groups participating in a 4-day program and an MS institute showed particularly strong gains compared to those in standard online care after one month.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Demonstrated in people
Mechanism
Not reported
Evidence strength
Limited
Outcome
Positive

Why it matters

These findings suggest that intensive and integrated care approaches for MS might lead to better outcomes in quality of life and self-management skills than standard care.

What this does not prove

The study had a small sample size, faced pandemic-related challenges, and one group had limited clinical data. Thus, results may not be widely applicable.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Interventional
Participants / samples
55 · basis not reported
Randomised
Not reported
Controlled
Not reported
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
2026-07-20
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified
Biological target
Not reported
Pathway
Not reported
Population
People with MS
Size of effect
Not reported
Secondary endpoints
Not reported
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (11)
peer reviewedPublication types: Journal Article
study designThis study was conducted at a nonprofit rehabilitation center.
subjectsParticipants were people with MS who (1) were in a 4-day comprehensive MS program (4Day; n = 24), (2) were receiving care in an MS institute (MSI; n = 10), or (3) were members of an online patient research platform (iConquerMS; iCMS; n = 21).
sample sizeParticipants were people with MS who (1) were in a 4-day comprehensive MS program (4Day; n = 24), (2) were receiving care in an MS institute (MSI; n = 10), or (3) were members of an online patient research platform (iConquerMS; iCMS; n = 21).
primary endpointThe 4Day and MSI groups had greater gains in self-management, self-efficacy, and quality of life, particularly at 1 month, compared with the iCMS group.
findingsAll groups showed improvements across most outcomes at 1 and 6 months. The 4Day and MSI groups had greater gains in self-management, self-efficacy, and quality of life, particularly at 1 month, compared with the iCMS group.
limitationsFurther research is needed due to small sample sizes, pandemic-related challenges, and limited clinical data for one group.
populationParticipants were people with MS who (1) were in a 4-day comprehensive MS program (4Day; n = 24), (2) were receiving care in an MS institute (MSI; n = 10), or (3) were members of an online patient research platform (iConquerMS; iCMS; n = 21).
outcomeCONCLUSIONS: Comprehensive MS care, whether delivered intensively over 4 days or through an integrated outpatient program, may enhance self-efficacy and quality of life more effectively than standard care alone.
human efficacyCONCLUSIONS: Comprehensive MS care, whether delivered intensively over 4 days or through an integrated outpatient program, may enhance self-efficacy and quality of life more effectively than standard care alone.
publication datePublication date: 2026-07-20

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.